Duration of Antibiotic Therapy in Neonatal Gram-negative Bacterial Sepsis—10 Days Versus 14 Days

Duration of Antibiotic Therapy in Neonatal Gram-negative Bacterial Sepsis—10 Days Versus 14 Days Background: Optimal duration of antibiotic therapy in Gram-negative bacterial (GNB) sepsis in non-VLBW infants has not been specifically evaluated in previous studies....

Infectious Diseases Society of America 2022 Guidance on the Treatment of ExtendedSpectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTRP. aeruginosa)

Infectious Diseases Society of America 2022 Guidance on the Treatment of ExtendedSpectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTRP. aeruginosa)...

Clinical Characteristics, Acute Complications, and Neurologic Outcomes of Salmonella Meningitis in Saudi Infants and Children

Clinical Characteristics, Acute Complications, and Neurologic Outcomes of Salmonella Meningitis in Saudi Infants and Children Objective This study aimed to clarify the clinical presentations, acute complications, and long-term sequelae of Salmonella meningitis in...

WHO consolidated guidelines on tuberculosis

WHO consolidated guidelines on tuberculosis Module 5: Management of tuberculosis in children and adolescents Provided by : Dr Rana Maghrabi Read...

Pharmacokinetic evaluation of twice-a-week micafungin for prophylaxis of invasive fungal disease in children with acute lymphoblastic leukaemia: a prospective observational cohort study

Pharmacokinetic evaluation of twice-a-week micafungin for prophylaxis of invasive fungal disease in children with acute lymphoblastic leukaemia: a prospective observational cohort study Objectives: To determine the pharmacokinetics of twice-a-week micafungin...

Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam

Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam Abstract: Antimicrobial resistance poses a substantial threat to global public health. The pursuit of new antibiotics has decreased and very few...

Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children

Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children ABSTRACT Invasive aspergillosis (IA) is associated with significant morbidity and mortality. Voriconazole remains the drug of choice for the treatment of IA in children; however, the...

Escherichia Coli Meningitis Features in 325 Children From 2001 to 2013 in France

Escherichia Coli Meningitis Features in 325 Children From 2001 to 2013 in France Background. We aimed to describe features of Escherichia coli meningitis in a large population of children and the molecular characteristics of the involved strains to determine factors...

CMV in pediatric patients

CMV in pediatric patients Purpose of review The purpose of this study is to explore the latest developments in the risk factors, prevention and treatment of cytomegalovirus (CMV) infection in immunocompromised children, including those with congenital immunodeficiency...

The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

 The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common complications affecting solid organ transplant recipients,...